Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (151-160 of 303) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|April 20, 2004
Can HIV-1 superinfection compromise antiretroviral therapy?Bikram Chakraborty, Patti Kiser, Hector R Rangel, et al.
AIDS (London, England)|June 24, 2003
T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatmentMireya Diaz, Daniel C Douek, Hernan Valdez, et al.
Journal of Virology|August 21, 2009
Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell functionSara J Conry, Kimberly A Milkovich, Nicole L Yonkers, et al.
Ebiomedicine|March 17, 2016
Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International StudyLaura W Musselwhite, Bruno B Andrade, Susan S Ellenberg, et al.
The Journal of Infectious Diseases|July 29, 2010
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core proteinRobert T Schooley, John Spritzler, Hongying Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2003
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group studyDavid W Haas, Hulin Wu, Haihong Li, et al.
Open Forum Infectious Diseases|August 28, 2023
Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular DiseaseMichael L Freeman, Mian B Hossain, Shana A B Burrowes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaborationDavid W Haas, John A Bartlett, Janet W Andersen, et al.
Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.
The Journal of Infectious Diseases|February 13, 2008
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patientsJacob Lalezari, Gopal K Yadavalli, Michael Para, et al.
Pageof 31

Showing results (151-160 of 303) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|April 20, 2004
Can HIV-1 superinfection compromise antiretroviral therapy?Bikram Chakraborty, Patti Kiser, Hector R Rangel, et al.
AIDS (London, England)|June 24, 2003
T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatmentMireya Diaz, Daniel C Douek, Hernan Valdez, et al.
Journal of Virology|August 21, 2009
Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell functionSara J Conry, Kimberly A Milkovich, Nicole L Yonkers, et al.
Ebiomedicine|March 17, 2016
Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International StudyLaura W Musselwhite, Bruno B Andrade, Susan S Ellenberg, et al.
The Journal of Infectious Diseases|July 29, 2010
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core proteinRobert T Schooley, John Spritzler, Hongying Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2003
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group studyDavid W Haas, Hulin Wu, Haihong Li, et al.
Open Forum Infectious Diseases|August 28, 2023
Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular DiseaseMichael L Freeman, Mian B Hossain, Shana A B Burrowes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaborationDavid W Haas, John A Bartlett, Janet W Andersen, et al.
Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.
The Journal of Infectious Diseases|February 13, 2008
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patientsJacob Lalezari, Gopal K Yadavalli, Michael Para, et al.
Pageof 31